Combined probiotic bacteria promotes intestinal epithelial barrier function in interleukin-10-gene-deficient mice

World Journal of Gastroenterology

Volumn 20, Issue 16, 2014, Pages 4636-4647

  Shi, Chen Zhang ^a   Chen, Hong Qi ^a   Liang, Yong ^a   Xia, Yang ^a   Yang, Yong Zhi ^a   Yang, Jun ^a   Zhang, Jun Dong ^b   Wang, Shu Hai ^b   Liu, Jing ^b   Qin, Huan Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Sine Pharmaceutical Company   (China)

Author keywords

Caco 2 monolayers; Interleukin 10 genedeficient mice; Intestinal barrier function; Probiotic bacteria; Tight junction proteins

Indexed keywords

BIFICO; CLAUDIN 1; GAMMA INTERFERON; OCCLUDIN; PROBIOTIC AGENT; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; IFNG PROTEIN, HUMAN; IL10 PROTEIN, MOUSE; INTERLEUKIN 10; TIGHT JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL INVASION; CONTROLLED STUDY; DIARRHEA; ELECTRIC RESISTANCE; ENTEROINVASIVE ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; INTESTINAL EPITHELIAL BARRIER FUNCTION; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; TRANSEPITHELIAL ELECTRICAL RESISTANCE; TRANSMISSION ELECTRON MICROSCOPY; WEIGHT REDUCTION; WESTERN BLOTTING; 129 MOUSE; ANIMAL; BODY WEIGHT; CACO 2 CELL LINE; COLITIS; COLON; DEFICIENCY; DISEASE MODEL; GENETICS; IMMUNOLOGY; IMPEDANCE; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PERMEABILITY; TIGHT JUNCTION; TIME; ULTRASTRUCTURE;

ANIMALS; BODY WEIGHT; CACO-2 CELLS; COLITIS; COLON; DISEASE MODELS, ANIMAL; ELECTRIC IMPEDANCE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTESTINAL MUCOSA; MICE, 129 STRAIN; MICE, KNOCKOUT; PERMEABILITY; PROBIOTICS; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899653311     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i16.4636     Document Type: Article

References (38)

1. Ventura M, O'Flaherty S, Claesson MJ, Turroni F, Klaenhammer TR, van Sinderen D, O'Toole PW. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol 2009; 7: 61-71 [PMID: 19029955 DOI: 10.1038/nrmicro2047]
2. Jia W, Li H, Zhao L, Nicholson JK. Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 2008; 7: 123-129 [PMID: 18239669 DOI: 10.1038/nrd2505]
3. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121: 580-591 [PMID: 11522742]
4. Natividad JM, Petit V, Huang X, de Palma G, Jury J, Sanz Y, Philpott D, Garcia Rodenas CL, McCoy KD, Verdu EF. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice. Inflamm Bowel Dis 2012; 18: 1434-1446 [PMID: 22162005 DOI: 10.1002/ibd.22848]
5. von Schillde MA, Hörmannsperger G, Weiher M, Alpert CA, Hahne H, Bäuerl C, van Huynegem K, Steidler L, Hrncir T, Pérez-Martínez G, Kuster B, Haller D. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 2012; 11: 387-396 [PMID: 22520466 DOI: 10.1016/ j.chom.2012.02.006]
6. Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N, Bruewer M. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1140-G1149 [PMID: 19221015 DOI: 10.1152/ajpgi.90534.2008]
7. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469: 543-547 [PMID: 21270894 DOI: 10.1038/nature09646]
8. Chen HQ, Yang J, Zhang M, Zhou YK, Shen TY, Chu ZX, Zhang M, Hang XM, Jiang YQ, Qin HL. Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice. Am J Physiol Gastrointest Liver Physiol 2010; 299: G1287-G1297 [PMID: 20884889 DOI: 10.1152/ajpgi. 00196.2010]
9. Fujiya M, Musch MW, Nakagawa Y, Hu S, Alverdy J, Kohgo Y, Schneewind O, Jabri B, Chang EB. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe 2007; 1: 299-308 [PMID: 18005709 DOI: 10.1016/ j.chom.2007.05.004]
10. Tash BR, Bewley MC, Russo M, Keil JM, Griffin KA, Sundstrom JM, Antonetti DA, Tian F, Flanagan JM. The occludin and ZO-1 complex, defined by small angle X-ray scattering and NMR, has implications for modulating tight junction permeability. Proc Natl Acad Sci USA 2012; 109: 10855-10860 [PMID: 22711802 DOI: 10.1073/pnas.1121390109]
11. Marchiando AM, Graham WV, Turner JR. Epithelial barriers in homeostasis and disease. Annu Rev Pathol 2010; 5: 119-144 [PMID: 20078218 DOI: 10.1146/annurev. pathol.4.110807.092135]
12. Li Q, Zhang Q, Wang C, Li N, Li J. Invasion of enteropathogenic Escherichia coli into host cells through epithelial tight junctions. FEBS J 2008; 275: 6022-6032 [PMID: 19016848 DOI: 10.1111/j.1742-4658.2008.06731.x]
13. Liu Z, Shen T, Zhang P, Ma Y, Qin H. Lactobacillus plantarum surface layer adhesive protein protects intestinal epithelial cells against tight junction injury induced by enteropathogenic Escherichia coli. Mol Biol Rep 2011; 38: 3471-3480 [PMID: 21086172 DOI: 10.1007/s11033-010-0457-8]
14. Zhang Q, Li Q, Wang C, Liu X, Li N, Li J. Enteropathogenic Escherichia coli changes distribution of occludin and ZO-1 in tight junction membrane microdomains in vivo. Microb Pathog 2010; 48: 28-34 [PMID: 19833191 DOI: 10.1016/ j.micpath.2009.10.002]
15. Babbin BA, Sasaki M, Gerner-Schmidt KW, Nusrat A, Klapproth JM. The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases. Am J Pathol 2009; 174: 1347-1357 [PMID: 19286565 DOI: 10.2353/ajpath.2009.080640]
16. Chen ML, Ge Z, Fox JG, Schauer DB. Disruption of tight junctions and induction of proinflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni. Infect Immun 2006; 74: 6581-6589 [PMID: 17015453 DOI: 10.1128/ iai.00958-06]
17. Viswanathan VK, Koutsouris A, Lukic S, Pilkinton M, Simonovic I, Simonovic M, Hecht G. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect Immun 2004; 72: 3218-3227 [PMID: 15155623 DOI: 10.1128/ iai.72.6.3218-3227.2004]
18. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300: 1430-1434 [PMID: 12775840 DOI: 10.1126/science.1081919]
19. Gueimonde M, Ouwehand A, Huhtinen H, Salminen E, Salminen S. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 2007; 13: 3985-3989 [PMID: 17663515]
20. Ewaschuk JB, Tejpar QZ, Soo I, Madsen K, Fedorak RN. The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Curr Gastroenterol Rep 2006; 8: 486-498 [PMID: 17105688]
21. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2: 1519 [PMID: 2892070]
22. Eser A, Thalhammer F, Burghuber F, Högenauer C, Stockenhuber F, Wenisch C, Widhalm K, Reinisch W. Probiotics for the prevention of antibiotic-induced diarrhea. Z Gastroenterol 2012; 50: 1089-1095 [PMID: 23059802 DOI: 10.1055/ s-0032-1312950]
23. Kamiya T, Shikano M, Wada T, Sasaki M, Joh T. The efficacy of probiotics in gastrointestinal disease. Nihon Rinsho 2008; 66: 1385-1390 [PMID: 18616132]
24. Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 2006; 6: 849-858 [PMID: 17024229 DOI: 10.1038/nri1956]
25. Saulnier DM, Spinler JK, Gibson GR, Versalovic J. Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 2009; 20: 135-141 [PMID: 19243931 DOI: 10.1016/j.copbio.2009.01.002]
26. Arrieta MC, Madsen K, Doyle J, Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 genedeficient mouse. Gut 2009; 58: 41-48 [PMID: 18829978 DOI: 10.1136/gut.2008.150888]
27. Baker NT, Graham LL. Campylobacter fetus translocation across Caco-2 cell monolayers. Microb Pathog 2010; 49: 260-272 [PMID: 20600794 DOI: 10.1016/j.micpath.2010.06.008]
28. Neunlist M, Toumi F, Oreschkova T, Denis M, Leborgne J, Laboisse CL, Galmiche JP, Jarry A. Human ENS regulates the intestinal epithelial barrier permeability and a tight junctionassociated protein ZO-1 via VIPergic pathways. Am J Physiol Gastrointest Liver Physiol 2003; 285: G1028-G1036 [PMID: 12881224 DOI: 10.1152/ajpgi.00066.2003]
29. Spencer DM, Veldman GM, Banerjee S, Willis J, Levine AD. Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 2002; 122: 94-105 [PMID: 11781285]
30. Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, Doni A, Fantini M, Sturm A, Borroni E, Repici A, Locati M, Malesci A, Dejana E, Danese S. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 2008; 135: 173-184 [PMID: 18514073 DOI: 10.1053/j.gastro.2008.04.002]
31. Scaldaferri F, Pizzoferrato M, Pecere S, Forte F, Gasbarrini A. Bacterial flora as a cause or treatment of chronic diarrhea. Gastroenterol Clin North Am 2012; 41: 581-602 [PMID: 22917165 DOI: 10.1016/j.gtc.2012.06.002]
32. Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 1999; 5: 262-270 [PMID: 10579119]
33. Rabizadeh S, Sears C. New horizons for the infectious diseases specialist: how gut microflora promote health and disease. Curr Infect Dis Rep 2008; 10: 92-98 [PMID: 18462581]
34. Rigby RJ, Hunt MR, Scull BP, Simmons JG, Speck KE, Helmrath MA, Lund PK. A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora. Gut 2009; 58: 1104-1112 [PMID: 19398439 DOI: 10.1136/gut.2008.157636]
35. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999; 116: 1107-1114 [PMID: 10220502]
36. Ouwehand AC, Isolauri E, Kirjavainen PV, Tölkko S, Salminen SJ. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol 2000; 30: 10-13 [PMID: 10728552]
37. Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Britton RA, Kalkum M, Versalovic J. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One 2012; 7: e31951 [PMID: 22384111 DOI: 10.1371/journal.pone.0031951]
38. Haller D, Bode C, Hammes WP, Pfeifer AM, Schiffrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000; 47: 79-87 [PMID: 10861268]